505
Participants
Start Date
March 4, 2017
Primary Completion Date
September 8, 2021
Study Completion Date
December 6, 2024
Nivolumab
Specified dose on specified days
Cisplatin
Specified dose on specified days
Vinorelbine
Specified dose on specified days
Gemcitabine
Specified dose on specified days
Docetaxel
Specified dose on specified days
Pemetrexed
Specified dose on specified days
Carboplatin
Specified dose on specified days
Paclitaxel
Specified dose on specified days
Ipilimumab
This arm is closed and no longer enrolling patients.
Local Institution - 0100, Taipei
Local Institution - 0102, New Taipei City
Local Institution, Budapest
Local Institution - 0023, Ciudad Autonoma de Buenos Aire
Local Institution - 0022, Capital Federal
Local Institution, Székesfehérvár
Local Institution - 0011, New York
Local Institution - 0099, Taipei
Local Institution - 0019, Athens
Local Institution - 0027, Albany
Local Institution - 0059, Marseille
Local Institution - 0018, Pittsburgh
Local Institution - 0080, Genova
Local Institution - 0010, Philadelphia
Local Institution - 0151, Baltimore
Local Institution - 0001, Baltimore
Local Institution - 0125, Fairfax
Local Institution - 0198, Fredericksburg
Local Institution - 0140, High Point
Local Institution - 0029, Madrid
Local Institution - 0031, Majadahonda - Madrid
Local Institution - 0013, Charleston
Local Institution - 0021, Charleston
Local Institution - 0146, Greenville
Northwest Georgia Oncology Center, P.C., Marietta
Local Institution - 0058, Toulouse
Local Institution - 0054, Orlando
Orlando Health, Inc., Orlando
Indian River Medical Center, Vero Beach
Local Institution - 0173, Hollywood
Local Institution - 0136, Miami
Local Institution - 0115, Istanbul
Local Institution - 0061, Rennes
Local Institution - 0062, Tours
Local Institution - 0092, Nashville
Local Institution - 0005, Nashville
Local Institution - 0090, Hattiesburg
Local Institution - 0186, Louisville
Local Institution - 0170, Lexington
Local Institution - 0149, Zanesville
MetroHealth Medical Center, Cleveland
Christ Hospital, Cincinnati
Local Institution - 0171, Fort Wayne
Local Institution - 0066, Ravenna
Local Institution - 0097, Busan
Local Institution - 0122, Thessaloniki
Local Institution - 0098, Hwasun
St Vincent Frontier Cancer Center, Billings
Local Institution - 0015, Chicago
Local Institution - 0002, Chicago
Illinois Cancer Specialists, Niles
Local Institution - 0113, Strasbourg
Local Institution - 0064, Pierre Benite Cedax
University Medical Center New Orleans, New Orleans
Local Institution - 0068, Bari
Local Institution - 0060, Paris
Local Institution - 0112, Paris
Local Institution - 0143, Tyler
Texas Oncology, Bedford
Local Institution - 0026, Waco
Local Institution - 0106, Houston
Local Institution - 0035, Austin
Southwest Cancer Center, Lubbock
Local Institution - 0153, Fort Bliss
Local Institution - 0025, Denver
Intermountain Medical Center, Murray
Local Institution - 0003, Salt Lake City
Southwest Regional Cancer Clinic, St. George
Local Institution - 0121, Glendale
Local Institution - 0032, Las Vegas
Local Institution - 0081, Los Angeles
Kaiser Permanente, Portland
Local Institution - 0139, Portland
Local Institution - 0161, Beijing
Local Institution, Beijing
Local Institution - 0156, Beijing
Local Institution, Changchun
Local Institution - 0165, Shanghai
Local Institution - 0160, Shanghai
Local Institution - 0050, Craiova
Local Institution - 0163, Tianjin
Local Institution - 0189, Hangzhou
Local Institution - 0183, Hangzhou
Local Institution - 0182, Hangzhou
Local Institution - 0179, Nanchang
Local Institution - 0166, Nanchang
Local Institution - 0051, Romania
Local Institution - 0107, Taichung
Local Institution - 0192, Changsha
Local Institution - 0175, Changsha
Local Institution - 0193, Changsha
Local Institution - 0190, Guangzhou
Local Institution - 0178, Chengdu
Local Institution - 0180, Xi'an
Local Institution - 0159, Xi'an
Local Institution - 0126, Bunkyo-ku
Local Institution - 0120, Shinjuku-ku
Local Institution - 0123, Yokohama
Local Institution - 0118, Kashiwa-shi
Local Institution - 0132, Sunto-gun
Local Institution - 0131, Nagoya
Local Institution - 0127, Osaka
Local Institution - 0119, Sakai-shi
Local Institution - 0133, Kobe
Local Institution - 0109, Hiroshima
Local Institution - 0111, Kitakyushu-shi
Local Institution - 0110, Fukushima
Local Institution - 0148, Sendai
Local Institution - 0007, Plainville
Local Institution - 0008, Boston
Southcoast Center For Cancer, Fairhaven
Local Institution - 0006, Newton
Local Institution - 0012, Detroit
Local Institution - 0009, Hackensack
Valley Hospital Luckow Pavili, Westwood
Texas Cancer Center - Sherman, Sherman
Local Institution - 0135, Burlington
Local Institution - 0079, Brasília
Local Institution - 0077, Belo Horizonte
Local Institution - 0076, Ijuí
Local Institution - 0073, Porto Alegre
Fundacao Pio Xii Hosp Cancer De Barretos, Barretos
Local Institution - 0075, Rio de Janeiro
Local Institution - 0095, Gatineau
Local Institution - 0138, Montreal
Local Institution - 0017, Montreal
Local Institution - 0052, Trois-Rivières
Local Institution - 0016, Saskatoon
Local Institution - 0070, Perugia
Local Institution - 0067, Roma
Local Institution - 0147, Sapporo
Local Institution - 0108, Osaka
Local Institution - 0124, Tokyo
Local Institution - 0042, Amsterdam
Local Institution - 0043, Groningen
Local Institution - 0069, Sector 2
Local Institution - 0105, Seoul
Local Institution - 0028, Barcelona
Local Institution - 0093, Adana
Local Institution - 0084, Ankara
Lead Sponsor
Collaborators (1)
Ono Pharmaceutical Co. Ltd
INDUSTRY
Bristol-Myers Squibb
INDUSTRY